Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Cancer|February 10, 2024
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndromeAshley Dinh, J Michael Savoy, Dimitrios P Kontoyiannis, et al.
Cancer|July 5, 2025
Management of chronic myeloid leukemia in 2025Hagop Kantarjian, Massimo Breccia, Fadi G Haddad, et al.
Cancer|May 28, 2024
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phaseFadi G Haddad, Koji Sasaki, Lewis Nasr, et al.
British Journal of Haematology|May 9, 2024
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous diseaseWei-Ying Jen, Hagop Kantarjian, Tapan M Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2023
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up ResultsGeorgina Gener-Ricos, Fadi G Haddad, Koji Sasaki, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 24, 2026
Outcomes of Patients Treated With Dasatinib 50 mg/d: A Pooled AnalysisFadi G Haddad, Elias Jabbour, Koji Sasaki, et al.
Molecular & Cellular Proteomics : MCP|February 1, 2026
High-throughput proteomic profiling to evaluate differentiation syndrome with menin inhibitionMiriam B Garcia, Bofei Wang, Irtiza Sheikh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2026
Immunophenotypic, Cytogenetic, and Molecular Characterization of NUP98-Rearranged Pediatric Myeloid NeoplasmsMahsa Khanlari, Wei Wang, Beenu Thakral, et al.
Haematologica|December 10, 2020
Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemiaIman Abou Dalle, Ronald Paranal, Jabra Zarka, et al.
Pageof 16